project id: TCGA-LUAD; case submitter id: TCGA-67-3770; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 0.9; rna integrity number: 8.1; spectrophotometer method: UV Spec; age at index: 70; days to birth: -25658; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1939; age at diagnosis: 25658; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IA; ajcc pathologic t: T1; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 610.0; icd 10 code: C34.1; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Upper lobe, lung; synchronous malignancy: No; tissue or organ of origin: Upper lobe, lung; tumor grade: Not Reported; year of diagnosis: 2009; treatment or therapy: not reported; alcohol history: Not Reported; is ffpe: false; portion number: 01; weight: 157.0; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 0.8; longest dimension: 0.9; oct embedded: No; shortest dimension: 0.2; portion submitter id: TCGA-67-3770-01A-01; percent necrosis: 3.0; percent normal cells: 5.0; percent stromal cells: 10.0; percent tumor cells: 82.0; percent tumor nuclei: 80.0;